Clinical Trials
5 trialsNCT04637503 2020-11-19
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown
NCT01701479 2020-07-14
LTI
St. Anna Kinderkrebsforschung
Phase 1/2 Unknown
NCT02173093 2019-01-29
Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma
University of Virginia
Phase 1/2 Unknown
NCT03242603 2018-03-30
NKEXPGD2
National University Hospital, Singapore
Phase 1/2 Unknown
NCT00798148 2012-06-04
131I-MIBG With Myeloablative Chemotherapy and Autologous Stem Cell Transplantation for the Treatment of High-risk Neuroblastoma
Tehran University of Medical Sciences
Phase 1/2 Unknown